[Management of panic disorder in the elderly].

IF 0.3 4区 医学 Q4 PSYCHIATRY
Maxime Pace, Mathilde Heckendorn, Bruno Aouizerate, Cécile Hanon, Anne-Sophie Seigneurie, Pierre Lavaud, Franz Hozer, Rachel Pascal De Raykeer, Christophe Guerin-Langlois, Lucile Cormier, Hélène Poncelin De Raucourt, Frédéric Limosin, Nicolas Hoertel
{"title":"[Management of panic disorder in the elderly].","authors":"Maxime Pace,&nbsp;Mathilde Heckendorn,&nbsp;Bruno Aouizerate,&nbsp;Cécile Hanon,&nbsp;Anne-Sophie Seigneurie,&nbsp;Pierre Lavaud,&nbsp;Franz Hozer,&nbsp;Rachel Pascal De Raykeer,&nbsp;Christophe Guerin-Langlois,&nbsp;Lucile Cormier,&nbsp;Hélène Poncelin De Raucourt,&nbsp;Frédéric Limosin,&nbsp;Nicolas Hoertel","doi":"10.1684/pnv.2020.0878","DOIUrl":null,"url":null,"abstract":"<p><p>Panic disorder in the elderly is an understudied disorder, despite being associated with substantial functional impairment, diminished quality of life and increased suicide risk in this population. This disorder is likely to be underdiagnosed and sometimes inadequately treated in the absence of national and international guidelines for this vulnerable population. Few therapeutic trials have specifically focused on the efficacy and tolerability of pharmacologic and psychotherapy treatments for panic disorder in the elderly, and current approaches to detect and manage this disorder are mainly based on experts' opinion or extrapolation from data available in younger adults. This report aims to provide a summary of current knowledge on pharmacologic and psychotherapeutic treatments for panic disorder in the elderly, and to propose a medical treatment algorithm, which should be viewed as a tool that may contribute to the choice of treatment, especially for treatment-resistant older patients with panic disorder. The main results here are the emphasis on antidepressant treatment, like selective serotonin reuptake inhibitor (SSRI), restricted benzodiazepine usage, take care of drug interactions, and importance of psychotherapy like cognitive behavioral therapy (CBT).</p>","PeriodicalId":51244,"journal":{"name":"Geriatrie et Psychologie Neuropsychiatrie De Vieillissement","volume":"18 3","pages":"295-304"},"PeriodicalIF":0.3000,"publicationDate":"2020-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Geriatrie et Psychologie Neuropsychiatrie De Vieillissement","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1684/pnv.2020.0878","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PSYCHIATRY","Score":null,"Total":0}
引用次数: 1

Abstract

Panic disorder in the elderly is an understudied disorder, despite being associated with substantial functional impairment, diminished quality of life and increased suicide risk in this population. This disorder is likely to be underdiagnosed and sometimes inadequately treated in the absence of national and international guidelines for this vulnerable population. Few therapeutic trials have specifically focused on the efficacy and tolerability of pharmacologic and psychotherapy treatments for panic disorder in the elderly, and current approaches to detect and manage this disorder are mainly based on experts' opinion or extrapolation from data available in younger adults. This report aims to provide a summary of current knowledge on pharmacologic and psychotherapeutic treatments for panic disorder in the elderly, and to propose a medical treatment algorithm, which should be viewed as a tool that may contribute to the choice of treatment, especially for treatment-resistant older patients with panic disorder. The main results here are the emphasis on antidepressant treatment, like selective serotonin reuptake inhibitor (SSRI), restricted benzodiazepine usage, take care of drug interactions, and importance of psychotherapy like cognitive behavioral therapy (CBT).

[老年人惊恐障碍的管理]。
在老年人中,恐慌症是一种未被充分研究的疾病,尽管它与严重的功能障碍、生活质量下降和自杀风险增加有关。在缺乏针对这一脆弱人群的国家和国际指南的情况下,这种疾病很可能被诊断不足,有时治疗不足。很少有治疗试验专门关注老年恐慌症的药物和心理治疗的疗效和耐受性,目前检测和管理这种疾病的方法主要基于专家的意见或从年轻人的可用数据推断。本报告旨在总结目前关于老年惊恐障碍的药物和心理治疗的知识,并提出一种医学治疗算法,该算法应被视为一种工具,可能有助于治疗选择,特别是对于治疗抵抗的老年惊恐障碍患者。这里的主要结果是强调抗抑郁治疗,如选择性血清素再摄取抑制剂(SSRI),限制苯二氮卓类药物的使用,注意药物相互作用,以及心理治疗的重要性,如认知行为疗法(CBT)。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
0.70
自引率
16.70%
发文量
0
审稿时长
6-12 weeks
期刊介绍: D''une qualité scientifique reconnue cette revue est, la première revue francophone gériatrique et psychologique indexée dans les principales bases de données internationales. Elle couvre tous les aspects médicaux, psychologiques, sanitaires et sociaux liés au suivi et à la prise en charge de la personne âgée. Que vous soyez psychologues, neurologues, psychiatres, gériatres, gérontologues,... vous trouverez à travers cette approche originale et unique, un veritable outil de formation, de réflexion et d''échanges indispensable à votre pratique professionnelle.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书